JPH0249719A - Oil soluble-vitamin powder having readily water-dispersible and soluble performance - Google Patents

Oil soluble-vitamin powder having readily water-dispersible and soluble performance

Info

Publication number
JPH0249719A
JPH0249719A JP20111888A JP20111888A JPH0249719A JP H0249719 A JPH0249719 A JP H0249719A JP 20111888 A JP20111888 A JP 20111888A JP 20111888 A JP20111888 A JP 20111888A JP H0249719 A JPH0249719 A JP H0249719A
Authority
JP
Japan
Prior art keywords
oil
soluble vitamin
vitamin
soluble
pts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP20111888A
Inventor
Yuji Hori
Masahisa Ibuki
Original Assignee
Dai Ichi Kogyo Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dai Ichi Kogyo Seiyaku Co Ltd filed Critical Dai Ichi Kogyo Seiyaku Co Ltd
Priority to JP20111888A priority Critical patent/JPH0249719A/en
Publication of JPH0249719A publication Critical patent/JPH0249719A/en
Application status is Pending legal-status Critical

Links

Abstract

PURPOSE: To obtain oil-soluble vitamin powder useful as formula feed for fish breeding, etc., having excellent water-dispersing and solubilizing ability comprising specific two emulsifying agents as essential components by coating and powdering an oil-soluble vitamin with melted polyethylene glycol.
CONSTITUTION: A polyoxyethylene sorbitan fatty acid ester to which ≤10mol<30mol ethylene oxide is added and a polyoxyethylene sorbitan fatty acid ester to which ≤30mol-≤50mol ethylene oxide is added are used as essential components for emulsifying agents and coated and powdered together with an oil-soluble vitamin (e. g. vitamin A or vitamin D) and melted polyethylene glycol. The blending ratio of the components is preferably ≥10 pts.wt. emulsifying agents based on 90 pts.wt. oil-soluble vitamin to stably disperse the oil- soluble vitamin. The amount of the polyethylene glycol is preferably ≥50 pts.wt. based on 50 pts.wt. total amounts of the emulsifying agents and the oil-soluble vitamin.
COPYRIGHT: (C)1990,JPO&Japio
JP20111888A 1988-08-11 1988-08-11 Oil soluble-vitamin powder having readily water-dispersible and soluble performance Pending JPH0249719A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20111888A JPH0249719A (en) 1988-08-11 1988-08-11 Oil soluble-vitamin powder having readily water-dispersible and soluble performance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20111888A JPH0249719A (en) 1988-08-11 1988-08-11 Oil soluble-vitamin powder having readily water-dispersible and soluble performance

Publications (1)

Publication Number Publication Date
JPH0249719A true JPH0249719A (en) 1990-02-20

Family

ID=16435703

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20111888A Pending JPH0249719A (en) 1988-08-11 1988-08-11 Oil soluble-vitamin powder having readily water-dispersible and soluble performance

Country Status (1)

Country Link
JP (1) JPH0249719A (en)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516535A (en) * 1992-11-19 1996-05-14 The Procter & Gamble Beverage compositions having enhanced β-carotene bioavailability
US6004567A (en) * 1996-03-20 1999-12-21 L'oreal Cosmetic compositions comprising nanopigments
FR2861261A1 (en) * 2003-10-22 2005-04-29 Adisseo France Sas The use in animal nutrition of alimentary emulsifiers, especially sorbitol monolaurate and monooleate in association with a derivative of vitamin E, especially tocopherol acetate to improve its bioavailability
KR20110016921A (en) * 2008-05-09 2011-02-18 그뤼넨탈 게엠베하 Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
US9629807B2 (en) 2003-08-06 2017-04-25 Grünenthal GmbH Abuse-proofed dosage form
US9636303B2 (en) 2010-09-02 2017-05-02 Gruenenthal Gmbh Tamper resistant dosage form comprising an anionic polymer
US9655853B2 (en) 2012-02-28 2017-05-23 Grünenthal GmbH Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
US9675610B2 (en) 2002-06-17 2017-06-13 Grünenthal GmbH Abuse-proofed dosage form
US9737490B2 (en) 2013-05-29 2017-08-22 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
US9750701B2 (en) 2008-01-25 2017-09-05 Grünenthal GmbH Pharmaceutical dosage form
US9855263B2 (en) 2015-04-24 2018-01-02 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
US9872835B2 (en) 2014-05-26 2018-01-23 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping
US9913814B2 (en) 2014-05-12 2018-03-13 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
US9925146B2 (en) 2009-07-22 2018-03-27 Grünenthal GmbH Oxidation-stabilized tamper-resistant dosage form
US10058548B2 (en) 2003-08-06 2018-08-28 Grünenthal GmbH Abuse-proofed dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US10080721B2 (en) 2009-07-22 2018-09-25 Gruenenthal Gmbh Hot-melt extruded pharmaceutical dosage form
US10130591B2 (en) 2003-08-06 2018-11-20 Grünenthal GmbH Abuse-proofed dosage form
US10154966B2 (en) 2013-05-29 2018-12-18 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles
US10201502B2 (en) 2011-07-29 2019-02-12 Gruenenthal Gmbh Tamper-resistant tablet providing immediate drug release
US10300141B2 (en) 2010-09-02 2019-05-28 Grünenthal GmbH Tamper resistant dosage form comprising inorganic salt
US10335373B2 (en) 2012-04-18 2019-07-02 Grunenthal Gmbh Tamper resistant and dose-dumping resistant pharmaceutical dosage form

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516535A (en) * 1992-11-19 1996-05-14 The Procter & Gamble Beverage compositions having enhanced β-carotene bioavailability
US6004567A (en) * 1996-03-20 1999-12-21 L'oreal Cosmetic compositions comprising nanopigments
US9675610B2 (en) 2002-06-17 2017-06-13 Grünenthal GmbH Abuse-proofed dosage form
US9629807B2 (en) 2003-08-06 2017-04-25 Grünenthal GmbH Abuse-proofed dosage form
US10058548B2 (en) 2003-08-06 2018-08-28 Grünenthal GmbH Abuse-proofed dosage form
US10130591B2 (en) 2003-08-06 2018-11-20 Grünenthal GmbH Abuse-proofed dosage form
FR2861261A1 (en) * 2003-10-22 2005-04-29 Adisseo France Sas The use in animal nutrition of alimentary emulsifiers, especially sorbitol monolaurate and monooleate in association with a derivative of vitamin E, especially tocopherol acetate to improve its bioavailability
US9750701B2 (en) 2008-01-25 2017-09-05 Grünenthal GmbH Pharmaceutical dosage form
US9161917B2 (en) 2008-05-09 2015-10-20 Grünenthal GmbH Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet
KR20110016921A (en) * 2008-05-09 2011-02-18 그뤼넨탈 게엠베하 Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
JP2011519886A (en) * 2008-05-09 2011-07-14 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Production method of the intermediate powder formulations and final solid dosage form under application of spray congealing step
US10080721B2 (en) 2009-07-22 2018-09-25 Gruenenthal Gmbh Hot-melt extruded pharmaceutical dosage form
US9925146B2 (en) 2009-07-22 2018-03-27 Grünenthal GmbH Oxidation-stabilized tamper-resistant dosage form
US10300141B2 (en) 2010-09-02 2019-05-28 Grünenthal GmbH Tamper resistant dosage form comprising inorganic salt
US9636303B2 (en) 2010-09-02 2017-05-02 Gruenenthal Gmbh Tamper resistant dosage form comprising an anionic polymer
US10201502B2 (en) 2011-07-29 2019-02-12 Gruenenthal Gmbh Tamper-resistant tablet providing immediate drug release
US9655853B2 (en) 2012-02-28 2017-05-23 Grünenthal GmbH Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
US10335373B2 (en) 2012-04-18 2019-07-02 Grunenthal Gmbh Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US10154966B2 (en) 2013-05-29 2018-12-18 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles
US9737490B2 (en) 2013-05-29 2017-08-22 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
US9913814B2 (en) 2014-05-12 2018-03-13 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
US9872835B2 (en) 2014-05-26 2018-01-23 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping
US9855263B2 (en) 2015-04-24 2018-01-02 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction

Similar Documents

Publication Publication Date Title
JPS62123112A (en) Ointment base
JPH04253919A (en) Oral pharmaceutical containing physiologically active protein
NZ255556A (en) Preparation of optically-clear compositions containing antioxidant, emulsifier, water and oil-soluble ingredient
TW349867B (en) Pharmaceutical composition for inducing a cytotoxic T-lymphocyte responses
JPS54113445A (en) Lipstick having sheath-core structure
JPS5317680A (en) Preparation of dispersed resin composition
JPH03127935A (en) Improving agent composition for bread
CA2009890A1 (en) Valproic acid
CA2375929A1 (en) Fat composition
JPS58198429A (en) Preparation of polyglycerol
JPS5910511A (en) Aqueous solution containing fat-soluble substance
JPS60188315A (en) Antipruritic plaster containing glycyrretic acid
JPS5659710A (en) Preventive and remedy for psoriasis
JPS5967214A (en) Cosmetic composition
JPS6272611A (en) Skin external preparation
JPS62270521A (en) Flurbiprofen preparation for ophthalmic administration
JPH0459897A (en) Wax composition for candle
JPS59133297A (en) High-temperature lubricating oil composition
JPS56131548A (en) Neopentylpolyol ester, and flon-resistant oil containing said ester as base oil
JPS58185647A (en) Stable polymer emulsion composition giving antithrombotic surface and preparation thereof
JPH0368505A (en) Oily lotion for external application
CA2336599A1 (en) Plant growth regulating formulations
JPH01151501A (en) Agricultural chemical coating agent
JPH01301757A (en) Silicon emulsion composition
EP0237436A3 (en) Soft soybean oil filler cream